Hoffmann-LaRoche
Executive Summary
Patrick Zenner, Roche Labs senior VP-pharmaceuticals, is moving to corporate headquarters in Basel on two-year assignment as director of project management and drug regulatory affairs. Zenner, who was also a member of the Roche executive committee and board, will assume his new position Jan. 1, 1989. He will remain at the parent company for two years, to "facilitate and enhance cooperation and collaboration between Basel and Nutley (N.J.) in the critical areas related to international development and registration of pharmaceutical products," according to a Roche announcement of the move.
You may also be interested in...
Biden Administration Is Setting An Example For Safe AI Use In Federal Organizations
A new memorandum by the Director of the Office of Management and Budget initiated a government-wide policy that will appoint AI officers to all agencies to address risks for AI use and serve as an example for greater AI adoption.
US FDA Drugs Center Ready To Break Down Silos On Regulatory Innovation
CDER Director Cavazzoni is promising to increase coordination and collaboration to accelerate broader adoption of innovative clinical trial designs and other approaches to speed drug development. A new "Quantitative Medicine Center of Excellence" illustrates the approach.
New OSP Director To Guide CDER-Wide IT Upgrades; System Enhancements Speed ANDA Assessments
Generic Drug Structured Assessment for Bioequivalence launched in 2023 and has been used in 40 ANDA reviews so far.